ASX - By Stock
|
OCC |
Re:
Ann: Strategic Placement to Raise $3.5 million
|
|
Ducks_Head
|
91 |
31K |
8 |
22/02/24 |
22/02/24 |
ASX - By Stock
|
91
|
31K
|
8
|
|
ASX - By Stock
|
OCC |
Re:
Ann: Strategic Placement to Raise $3.5 million
|
|
Ducks_Head
|
91 |
31K |
4 |
22/02/24 |
22/02/24 |
ASX - By Stock
|
91
|
31K
|
4
|
|
ASX - By Stock
|
OCC |
Re:
Ann: Strategic Placement to Raise $3.5 million
|
|
Ducks_Head
|
91 |
31K |
17 |
22/02/24 |
22/02/24 |
ASX - By Stock
|
91
|
31K
|
17
|
|
ASX - By Stock
|
OCC |
Re:
Media thread
|
|
Ducks_Head
|
730 |
258K |
1 |
01/02/24 |
01/02/24 |
ASX - By Stock
|
730
|
258K
|
1
|
|
ASX - By Stock
|
OCC |
Re:
OCC Trading
|
|
Ducks_Head
|
1.8K |
573K |
1 |
22/11/23 |
22/11/23 |
ASX - By Stock
|
1.8K
|
573K
|
1
|
|
ASX - By Stock
|
OCC |
Re:
OCC Trading
|
|
Ducks_Head
|
1.8K |
573K |
2 |
22/11/23 |
22/11/23 |
ASX - By Stock
|
1.8K
|
573K
|
2
|
|
ASX - By Stock
|
OCC |
Re:
OCC Trading
|
|
Ducks_Head
|
1.8K |
573K |
1 |
22/11/23 |
22/11/23 |
ASX - By Stock
|
1.8K
|
573K
|
1
|
|
ASX - By Stock
|
OCC |
Re:
OCC Trading
|
|
Ducks_Head
|
1.8K |
573K |
1 |
22/11/23 |
22/11/23 |
ASX - By Stock
|
1.8K
|
573K
|
1
|
|
ASX - By Stock
|
OCC |
Re:
OCC Trading
|
|
Ducks_Head
|
1.8K |
573K |
1 |
13/11/23 |
13/11/23 |
ASX - By Stock
|
1.8K
|
573K
|
1
|
|
ASX - By Stock
|
OCC |
Re:
Media thread
|
|
Ducks_Head
|
730 |
258K |
5 |
12/10/23 |
12/10/23 |
ASX - By Stock
|
730
|
258K
|
5
|
|
ASX - By Stock
|
OCC |
Re:
Ann: Annual Report to Shareholders
|
|
Ducks_Head
|
5 |
2.8K |
7 |
04/10/23 |
04/10/23 |
ASX - By Stock
|
5
|
2.8K
|
7
|
|
ASX - By Stock
|
OCC |
Re:
Ann: Striate re-certified under new European medical device regs
|
|
Ducks_Head
|
17 |
6.0K |
2 |
24/08/23 |
24/08/23 |
ASX - By Stock
|
17
|
6.0K
|
2
|
|
ASX - By Stock
|
OCC |
Re:
News: OCC Orthocell Says Striate+™ Re-Certified Under New European Medical Device Regulations
|
|
Ducks_Head
|
2 |
763 |
1 |
24/08/23 |
24/08/23 |
ASX - By Stock
|
2
|
763
|
1
|
|
ASX - By Stock
|
OCC |
Re:
OCC Trading
|
|
Ducks_Head
|
1.8K |
573K |
3 |
04/04/23 |
04/04/23 |
ASX - By Stock
|
1.8K
|
573K
|
3
|
|
ASX - By Stock
|
OCC |
Re:
OCC Trading
|
|
Ducks_Head
|
1.8K |
573K |
0 |
04/04/23 |
04/04/23 |
ASX - By Stock
|
1.8K
|
573K
|
0
|
|
ASX - By Stock
|
OCC |
Re:
Ann: Leading US-based nerve surgeons appointed to advisory board
|
|
Ducks_Head
|
32 |
10K |
9 |
30/03/23 |
30/03/23 |
ASX - By Stock
|
32
|
10K
|
9
|
|
ASX - By Stock
|
OCC |
Re:
Ann: Leading US-based nerve surgeons appointed to advisory board
|
|
Ducks_Head
|
32 |
10K |
8 |
29/03/23 |
29/03/23 |
ASX - By Stock
|
32
|
10K
|
8
|
|
ASX - By Stock
|
OCC |
Re:
OCC Trading
|
|
Ducks_Head
|
1.8K |
573K |
2 |
16/03/23 |
16/03/23 |
ASX - By Stock
|
1.8K
|
573K
|
2
|
|
ASX - By Stock
|
OCC |
Re:
Ann: Orthocell Appoints Non-Executive Director Dr Ravi Thadhani
|
|
Ducks_Head
|
47 |
15K |
7 |
08/03/23 |
08/03/23 |
ASX - By Stock
|
47
|
15K
|
7
|
|
ASX - By Stock
|
OCC |
Re:
Ann: Appendix 4C - Quarterly
|
|
Ducks_Head
|
28 |
8.4K |
13 |
30/01/23 |
30/01/23 |
ASX - By Stock
|
28
|
8.4K
|
13
|
|
ASX - By Stock
|
OCC |
Re:
Bio Horizons is marketing Sriate+ directly on its homepage
|
|
Ducks_Head
|
74 |
30K |
6 |
25/11/22 |
25/11/22 |
ASX - By Stock
|
74
|
30K
|
6
|
|
ASX - By Stock
|
OCC |
Re:
Ann: Investor Presentation
|
|
Ducks_Head
|
45 |
18K |
9 |
21/11/22 |
21/11/22 |
ASX - By Stock
|
45
|
18K
|
9
|
|
ASX - By Stock
|
OCC |
Re:
Ann: Investor Presentation
|
|
Ducks_Head
|
45 |
18K |
8 |
21/11/22 |
21/11/22 |
ASX - By Stock
|
45
|
18K
|
8
|
|
ASX - By Stock
|
OCC |
Re:
Bio Horizons is marketing Sriate+ directly on its homepage
|
|
Ducks_Head
|
74 |
30K |
6 |
15/11/22 |
15/11/22 |
ASX - By Stock
|
74
|
30K
|
6
|
|
ASX - By Stock
|
OCC |
Re:
Bio Horizons is marketing Sriate+ directly on its homepage
|
|
Ducks_Head
|
74 |
30K |
1 |
15/11/22 |
15/11/22 |
ASX - By Stock
|
74
|
30K
|
1
|
|
ASX - By Stock
|
OCC |
Re:
Bio Horizons is marketing Sriate+ directly on its homepage
|
|
Ducks_Head
|
74 |
30K |
4 |
08/11/22 |
08/11/22 |
ASX - By Stock
|
74
|
30K
|
4
|
|
ASX - By Stock
|
OCC |
Re:
Ann: Appendix 4C - Quarterly
|
|
Ducks_Head
|
18 |
7.7K |
2 |
29/07/22 |
29/07/22 |
ASX - By Stock
|
18
|
7.7K
|
2
|
|
ASX - By Stock
|
OCC |
Re:
Ann: Appendix 4C - Quarterly
|
|
Ducks_Head
|
18 |
7.7K |
7 |
29/07/22 |
29/07/22 |
ASX - By Stock
|
18
|
7.7K
|
7
|
|
ASX - By Stock
|
OCC |
Re:
Ann: Appendix 4C - Quarterly
|
|
Ducks_Head
|
18 |
7.7K |
4 |
29/07/22 |
29/07/22 |
ASX - By Stock
|
18
|
7.7K
|
4
|
|
ASX - By Stock
|
OCC |
Re:
Ann: OCC Signs Striate Global License And Manufacturing Agreement
|
|
Ducks_Head
|
298 |
88K |
3 |
01/07/22 |
01/07/22 |
ASX - By Stock
|
298
|
88K
|
3
|
|
ASX - By Stock
|
OCC |
Re:
Ann: OCC Signs Striate Global License And Manufacturing Agreement
|
|
Ducks_Head
|
298 |
88K |
5 |
01/07/22 |
01/07/22 |
ASX - By Stock
|
298
|
88K
|
5
|
|
ASX - By Stock
|
OCC |
Re:
Ann: OCC Signs Striate Global License And Manufacturing Agreement
|
|
Ducks_Head
|
298 |
88K |
2 |
01/07/22 |
01/07/22 |
ASX - By Stock
|
298
|
88K
|
2
|
|
ASX - By Stock
|
OCC |
Re:
Ann: OCC Signs Striate Global License And Manufacturing Agreement
|
|
Ducks_Head
|
298 |
88K |
8 |
01/07/22 |
01/07/22 |
ASX - By Stock
|
298
|
88K
|
8
|
|
ASX - By Stock
|
OCC |
Re:
Ann: OCC Signs Striate Global License And Manufacturing Agreement
|
|
Ducks_Head
|
298 |
88K |
0 |
30/06/22 |
30/06/22 |
ASX - By Stock
|
298
|
88K
|
0
|
|
ASX - By Stock
|
OCC |
Re:
Ann: OCC Signs Striate Global License And Manufacturing Agreement
|
|
Ducks_Head
|
298 |
88K |
4 |
30/06/22 |
30/06/22 |
ASX - By Stock
|
298
|
88K
|
4
|
|
ASX - By Stock
|
OCC |
Re:
Ann: OCC Signs Striate Global License And Manufacturing Agreement
|
|
Ducks_Head
|
298 |
88K |
3 |
30/06/22 |
30/06/22 |
ASX - By Stock
|
298
|
88K
|
3
|
|
ASX - By Stock
|
OCC |
Re:
Ann: OCC Signs Striate Global License And Manufacturing Agreement
|
|
Ducks_Head
|
298 |
88K |
4 |
30/06/22 |
30/06/22 |
ASX - By Stock
|
298
|
88K
|
4
|
|
ASX - By Stock
|
OCC |
Re:
Ann: OCC Signs Striate Global License And Manufacturing Agreement
|
|
Ducks_Head
|
298 |
88K |
1 |
29/06/22 |
29/06/22 |
ASX - By Stock
|
298
|
88K
|
1
|
|
ASX - By Stock
|
OCC |
Re:
Ann: OCC Signs Striate Global License And Manufacturing Agreement
|
|
Ducks_Head
|
298 |
88K |
3 |
29/06/22 |
29/06/22 |
ASX - By Stock
|
298
|
88K
|
3
|
|
ASX - By Stock
|
OCC |
Re:
Ann: OCC Signs Striate Global License And Manufacturing Agreement
|
|
Ducks_Head
|
298 |
88K |
11 |
27/06/22 |
27/06/22 |
ASX - By Stock
|
298
|
88K
|
11
|
|
ASX - By Stock
|
OCC |
Re:
Ann: Final Data Readout for Orthocells Nerve Reconstruction Study
|
|
Ducks_Head
|
59 |
20K |
4 |
07/06/22 |
07/06/22 |
ASX - By Stock
|
59
|
20K
|
4
|
|
ASX - By Stock
|
OCC |
Re:
OCC Trading
|
|
Ducks_Head
|
1.8K |
573K |
7 |
23/05/22 |
23/05/22 |
ASX - By Stock
|
1.8K
|
573K
|
7
|
|
ASX - By Stock
|
OCC Biotech |
Re:
Ortho-ACL (Rope)
|
|
Ducks_Head
|
35 |
17K |
2 |
10/04/22 |
10/04/22 |
ASX - By Stock
|
35
|
17K
|
2
|
|
ASX - By Stock
|
OCC Biotech |
Re:
Ortho-ACL (Rope)
|
|
Ducks_Head
|
35 |
17K |
2 |
10/04/22 |
10/04/22 |
ASX - By Stock
|
35
|
17K
|
2
|
|
ASX - By Stock
|
OCC |
Re:
Ann: Regulatory Approval for Remplir Nerve Repair Device
|
|
Ducks_Head
|
111 |
41K |
6 |
25/03/22 |
25/03/22 |
ASX - By Stock
|
111
|
41K
|
6
|
|
ASX - By Stock
|
OCC |
Re:
Ann: Regulatory Approval for Remplir Nerve Repair Device
|
|
Ducks_Head
|
111 |
41K |
0 |
25/03/22 |
25/03/22 |
ASX - By Stock
|
111
|
41K
|
0
|
|
ASX - By Stock
|
OCC |
Re:
Ann: Regulatory Approval for Remplir Nerve Repair Device
|
|
Ducks_Head
|
111 |
41K |
0 |
25/03/22 |
25/03/22 |
ASX - By Stock
|
111
|
41K
|
0
|
|
ASX - By Stock
|
OCC |
Re:
Ann: Regulatory Approval for Remplir Nerve Repair Device
|
|
Ducks_Head
|
111 |
41K |
1 |
25/03/22 |
25/03/22 |
ASX - By Stock
|
111
|
41K
|
1
|
|
ASX - By Stock
|
OCC |
Re:
Ann: Regulatory Approval for Remplir Nerve Repair Device
|
|
Ducks_Head
|
111 |
41K |
1 |
25/03/22 |
25/03/22 |
ASX - By Stock
|
111
|
41K
|
1
|
|
ASX - By Stock
|
OCC |
Re:
Ann: Trading Halt
|
|
Ducks_Head
|
106 |
36K |
1 |
21/03/22 |
21/03/22 |
ASX - By Stock
|
106
|
36K
|
1
|
|